CRP and cancer: On the other side, serum LPC was decreased by elevated inflammatory status, such as insulin resistance, nonalcoholic steatohepatitis (NASH), and cancer-involved inflammation, where negative correlations were found between LPC and inflammatory markers (CRP and TNF-α) [34–36].